Regulatory framework of manufacturing facility for medical devices as per USFDA, CDSCO & ISO 13485 AQBD approach

By:

Material type: Text

TextDescription: vii,113Dissertation note: LAKSHMEESHA C.S.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Date due	Barcode
ACP-Thesis & Dissertations	Acharya & BM Reddy College of Pharmacy Reference	Acharya & BM Reddy College of Pharmacy	ACP-Thesis and Dissertations	615.19 LAH (Browse shelf(Opens below))	Not for loan		ACP-T588

Previous	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	Next
Previous	615.19 CHE Design synthesis and anticancer study of novel heterocyclic componds as a B-RAF inhibitors for the treatment	615.19 DAS Pyrimidine-quinazoline based discoidin domain receptor inhibitors: Design Synthesis & in-vitro anti-cancer study.	615.19 DEE Regulatory framework of combination products in USA and EV a comparative study	615.19 LAH Regulatory framework of manufacturing facility for medical devices as per USFDA, CDSCO & ISO 13485 AQBD approach	615.19 MET Synthesis, Chemical stability and comparative Pharmacological Evaluation of Indolizine derivatives of Anti-hypertensive and Anti-diabetic agents	615.19 NAF Study on current US regulations for labelling of medicinal products and its future perspective	615.19 NAV Comparative study of marketing authorization of medical devices in US, EU and India.	Next

LAKSHMEESHA C.S.

There are no comments on this title.

to post a comment.